Baugh & Associates’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.17M Sell
184,359
-10,292
-5% -$233K 2.17% 23
2025
Q1
$4.71M Buy
194,651
+483
+0.2% +$11.7K 2.38% 24
2024
Q4
$4.97M Buy
194,168
+29,025
+18% +$743K 2.58% 15
2024
Q3
$4.6M Buy
165,143
+997
+0.6% +$27.8K 2.37% 22
2024
Q2
$4.79M Sell
164,146
-7,360
-4% -$215K 2.49% 21
2024
Q1
$4.76M Buy
171,506
+43,907
+34% +$1.22M 2.53% 18
2023
Q4
$3.67M Sell
127,599
-5,813
-4% -$167K 2.11% 25
2023
Q3
$4.43M Buy
133,412
+19,323
+17% +$641K 2.77% 16
2023
Q2
$4.18M Buy
114,089
+1,890
+2% +$69.3K 2.52% 17
2023
Q1
$4.66M Sell
112,199
-2,270
-2% -$94.3K 2.98% 14
2022
Q4
$5.87M Sell
114,469
-120
-0.1% -$6.15K 3.8% 9
2022
Q3
$5.01M Buy
114,589
+1,538
+1% +$67.3K 3.55% 10
2022
Q2
$5.93M Sell
113,051
-1,189
-1% -$62.3K 3.99% 8
2022
Q1
$5.91M Sell
114,240
-355
-0.3% -$18.4K 3.48% 11
2021
Q4
$6.77M Sell
114,595
-85
-0.1% -$5.02K 3.74% 8
2021
Q3
$4.93M Sell
114,680
-187
-0.2% -$8.04K 3.02% 12
2021
Q2
$4.5M Sell
114,867
-1,000
-0.9% -$39.2K 2.79% 12
2021
Q1
$4.2M Buy
115,867
+12,419
+12% +$450K 2.77% 13
2020
Q4
$3.81M Sell
103,448
-1,817
-2% -$66.9K 2.71% 17
2020
Q3
$3.67M Sell
105,265
-1,571
-1% -$54.7K 2.88% 14
2020
Q2
$3.32M Buy
106,836
+3,147
+3% +$97.6K 2.65% 17
2020
Q1
$3.21M Sell
103,689
-1,754
-2% -$54.3K 3.1% 14
2019
Q4
$3.92M Buy
105,443
+3,474
+3% +$129K 2.86% 14
2019
Q3
$3.48M Buy
101,969
+4,488
+5% +$153K 2.69% 20
2019
Q2
$4.01M Sell
97,481
-2,272
-2% -$93.4K 3.18% 7
2019
Q1
$4.02M Sell
99,753
-731
-0.7% -$29.5K 3.22% 9
2018
Q4
$4.16M Sell
100,484
-428
-0.4% -$17.7K 3.58% 4
2018
Q3
$4.22M Buy
100,912
+854
+0.9% +$35.7K 3.37% 7
2018
Q2
$3.44M Sell
100,058
-8,302
-8% -$286K 3% 11
2018
Q1
$3.65M Buy
108,360
+9,098
+9% +$306K 2.94% 13
2017
Q4
$3.41M Buy
+99,262
New +$3.41M 2.88% 18